Common IBS medications linked to higher risk of death in major study

A new large-scale study led by researchers at Cedars-Sinai Health Sciences University is raising questions about the long-term safety of some medications commonly used to treat irritable bowel syndrome (IBS). The findings suggest that certain…

Continue Reading

News Source: www.sciencedaily.com